For example, by targeting PLK1, the small molecule inhibitor BI-2536 not only inhibited cancer cell proliferation, but also induced mitochondrial fusion, G2/M-phase blockade, and apoptosis in neuroblastoma cells [39,40]. Here, PLK1 is linked to neuroblastoma.